International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7748460
Original Article
Retrospective Study on Seroprevalence of HIV, Hepatitis B, Hepatitis C and Syphilis Among Blood Donors in a Rural Tertiary Care Hospital
 ,
 ,
 ,
Published
March 18, 2023
Abstract
Background: Blood safety begins with a healthy donor. Collecting blood which is safe for transfusion is one of the principal challenges in the health care system. Transfusion of a contaminated blood increases the morbidity and mortality of the recipient. Aims and objectives: The aim of the present study was to estimate the seroprevalence of Transfusion Transmissible Infections(TTI’s) among blood donors and to estimate the prevalence of co-infection rate. Materials and methods: A retrospective study was conducted at Adichunchanagiri hospital and research centre, B.G. Nagara for a period of two years and involved testing of 3831 blood donors, who were serologically screened for HIV, HCV, HBV and Syphilis at the blood bank. Results: For a period of 2 years, a total of 3831 donors were tested. Among them 2339(61.05%) were voluntary donors and 1492(38.94%) were replacement donors. Male donors constituted for about 2681(69.98%) and females 1150(30.01%). Overall seropositivity for all TTI’s was 1.33%. Seropositivity was more among voluntary donors(0.83%) compared to replacement donors(0.5%). Seroprevalence of HIV is 0.10%, HBV is 0.96%, HCV is 0.26%, Syphilis is 0%. There were no occurrence of concomitant infections in the present study. Conclusion: Seroprevalence of HBV was more among voluntary donors, HIV and HCV seroprevalence was higher among replacement donors. Hence thorough screening of blood donors is must to prevent TTI’s to recipients. Category: Infectious diseases, Serology
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2853 Views
447 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved